pd 98059 and likviriton

pd 98059 has been researched along with likviriton in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, Y; Lu, J; Meng, Q; Teng, L; Wang, D; Wang, Z; Xie, J	1

Other Studies

1 other study(ies) available for pd 98059 and likviriton

Article	Year
Liquiritin modulates ERK‑ and AKT/GSK‑3β‑dependent pathways to protect against glutamate‑induced cell damage in differentiated PC12 cells. Molecular medicine reports, 2014, Volume: 10, Issue:2 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cytochromes c; Extracellular Signal-Regulated MAP Kinases; Flavanones; Flavonoids; Glucosides; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Membrane Potential, Mitochondrial; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction	2014

Article

Year

Liquiritin modulates ERK‑ and AKT/GSK‑3β‑dependent pathways to protect against glutamate‑induced cell damage in differentiated PC12 cells.

Molecular medicine reports, 2014, Volume: 10, Issue:2

Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cytochromes c; Extracellular Signal-Regulated MAP Kinases; Flavanones; Flavonoids; Glucosides; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Membrane Potential, Mitochondrial; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction

2014